|
|
楼主 |
发表于 2025-5-3 20:37:44
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-5-3 20:41 编辑
* Y7 B0 l" K$ q* A$ W4 z- o) F; i' h8 d- \) A
今年ASCO大会，肿瘤内科三大BU——头颈肿瘤、胸部肿瘤、腹部肿瘤中表现相对好的是头颈肿瘤BU，腹部肿瘤和生物治疗科今年哑火了9 ?3 X/ _! T- N0 d0 V+ f
# Y/ P q3 ]; o头颈肿瘤BU入选ASCO 2025的研究3 q' V: A0 l- s' U' h3 h
Hot flashes and night sweats in women with breast cancer: Prevalence and severity of symptoms.
& `7 q( Z, S! z3 ~5 Y# m4 _/ m肿瘤内科-头颈肿瘤科姜愚团队# p' w0 ?+ A% ~+ ]; n
( @5 r) }; z. B) C% INeoadjuvant immunotherapy in combination with chemotherapy in resectable locally advanced head and neck squamous cell carcinoma: A randomized, open label, phase II clinical trial.! U: \2 a3 m/ S1 s. X
肿瘤内科-头颈肿瘤科刘磊团队
) K. l1 ^" z6 i x P1 o0 @" u! `9 X
A phase II study of AK117 combined with cetuximab or AK104 in the treatment of recurrent or metastatic head and neck squamous cell carcinoma after the failure of PD-1 (L1) inhibitors and/or platinum-based therapy./ T" d" g+ Y) Z, t" R
肿瘤内科-头颈肿瘤科刘磊团队, A4 }7 @# u2 s- e
) w& O" e+ s& K' d. GA phase II randomized trial of nano-crystalline megestrol acetate for nutritional improvement in postoperative head and neck squamous cell carcinoma undergoing radiotherapy.
1 W2 A' d0 f6 x! V* K肿瘤内科-头颈肿瘤科刘磊团队
$ n4 E8 o' q3 W! s& d6 Q% B6 F
/ T/ ]' p, G# i# _1 Uribulin plus anlotinib in advanced soft tissue sarcoma (ERAS): Updates on efficacy and biomarkers.
' g2 A4 ^, Q2 h3 g6 `; T* x0 w2 j肿瘤内科-头颈肿瘤科姜愚团队. r# g5 O, r' O* H
|
|
[复制链接]
发表于 2025-5-9 16:51:15
